Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Change in Cash (2016 - 2025)

Historic Change in Cash for Nephros (NEPH) over the last 17 years, with Q3 2025 value amounting to $97000.0.

  • Nephros' Change in Cash rose 11556.98% to $97000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year increase of 22535.8%. This contributed to the annual value of -$547000.0 for FY2024, which is 18127.79% down from last year.
  • Per Nephros' latest filing, its Change in Cash stood at $97000.0 for Q3 2025, which was up 11556.98% from $993000.0 recorded in Q2 2025.
  • Nephros' 5-year Change in Cash high stood at $1.3 million for Q4 2024, and its period low was -$1.6 million during Q1 2022.
  • For the 5-year period, Nephros' Change in Cash averaged around -$162000.0, with its median value being -$239000.0 (2022).
  • Per our database at Business Quant, Nephros' Change in Cash plummeted by 170465.12% in 2022 and then surged by 51365.08% in 2024.
  • Quarter analysis of 5 years shows Nephros' Change in Cash stood at -$377000.0 in 2021, then increased by 18.83% to -$306000.0 in 2022, then dropped by 2.94% to -$315000.0 in 2023, then soared by 513.65% to $1.3 million in 2024, then crashed by 92.56% to $97000.0 in 2025.
  • Its Change in Cash was $97000.0 in Q3 2025, compared to $993000.0 in Q2 2025 and $321000.0 in Q1 2025.